23andMe to Report FY2022 Second Quarter Financial Results on November 10, 2021
October 20, 2021 18:30 ET
|
23andMe, Inc.
SUNNYVALE, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will report financial...
23andMe to Present at the Wells Fargo Healthcare Conference
September 01, 2021 16:05 ET
|
23andMe, Inc.
SUNNYVALE, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that management will be...
23andMe Reports FY2022 First Quarter Financial Results
August 13, 2021 07:00 ET
|
23andMe, Inc.
First quarter revenue up 23% over prior yearStrong cash balance of $770 millionContinuing to advance therapeutics portfolio to drive future revenue growth SUNNYVALE, Calif., Aug. 13, 2021 ...
23andMe to Report FY2022 First Quarter Financial Results
July 29, 2021 07:00 ET
|
23andMe, Inc.
SUNNYVALE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will report financial...
Industry Leaders Join 23andMe Board of Directors
June 21, 2021 08:00 ET
|
23andMe, Inc.
SUNNYVALE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that, following the June 16...
23andMe Successfully Closes its Business Combination with VG Acquisition Corp.
June 16, 2021 17:29 ET
|
23andMe, Inc.
SUNNYVALE, Calif. and NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- 23andMe, Inc., a leading consumer genetics and research company, and VG Acquisition Corp. (NYSE: VGAC), a special purpose...